Pilot And Phase II Trial Of Irinotecan And Radiation Followed By Irinotecan And BCNU [carmustine] In Glioblastoma Multiforme Patients
Phase of Trial: Phase I/II
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Irinotecan (Primary) ; Carmustine
- Indications Glioblastoma
- Focus Therapeutic Use
- 21 Jul 2009 Actual end date (July 2009) added as reported by ClinicalTrials.gov.
- 21 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Sep 2005 New trial record.